Table 2.
Laboratory and ECG Monitoring.
| Labs | Baseline | Supratherapeutic concentration | N at baseline and supratherapeutic concentration |
|---|---|---|---|
| Potassium (mmol/L), median [IQR] | 4.3 [3.9–4.5] | 4.0 [3.6–4.6] | 76, 85 |
| Bicarbonate (mmol/L), median [IQR] | 23 [22–26] | 25 [23–27] | 59, 69 |
| ALT (U/L), median [IQR] | 22 [16–36] | 31 [20–44] | 82, 86 |
| AST (U/L), median [IQR] | 23 [19–37] | 29 [22–43] | 79, 82 |
| Total bilirubin (mg/dL), median [IQR] | 0.4 [0.2–0.5] | 0.5 [0.3–0.6] | 79, 78 |
| Alk phos (U/L), median [IQR] | 87 [70–121] | 90 [74–130 | 80, 84 |
| QTc (ms), median [IQR] | 442 [427–463] | 456 [435–479] | 47, 48 |
ECG, electrocardiogram; IQR, interquartile range; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Alk Phos, alkaline phosphatase; QTc, corrected QT interval.